Position in GERN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$18,631,621
-$1,737,847 QoQ
Shares Held
14,555,954
+6.5% QoQ
Ownership
2.27%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 258 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GERN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,426,307 across 521 Biotechnology names. GERN ranks #141 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in GERN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,631,621 | 14,555,954 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $20,369,468 | 13,670,785 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $17,196,081 | 13,027,335 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $17,979,248 | 13,123,540 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $19,954,372 | 14,152,038 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $21,572,474 | 13,567,594 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $46,520,959 | 13,141,514 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $59,328,715 | 13,067,999 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $54,428,120 | 12,836,821 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $37,705,750 | 11,425,985 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $23,091,099 | 10,943,649 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $21,227,352 | 10,012,902 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $29,902,427 | 9,315,398 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $17,537,614 | 8,081,850 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $15,551,125 | 6,426,085 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $14,454,198 | 6,177,008 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $9,814,440 | 6,331,897 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $7,799,693 | 5,735,069 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $6,674,155 | 5,470,619 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $7,660,054 | 5,591,281 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $7,299,974 | 5,177,287 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $7,679,724 | 4,860,585 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $7,248,005 | 4,558,494 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $7,912,422 | 4,547,369 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $8,750,748 | 4,014,105 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $3,257,334 | 2,737,256 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||